首页 > 最新文献

Virologica Sinica最新文献

英文 中文
A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1 二价 Delta/BA.5 mRNA 疫苗可针对包括 JN.1 在内的多种 SARS-CoV-2 株系引起广泛的免疫反应。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1016/j.virs.2024.08.003
Kangyin Li , Qi Liu , Yan Wu , Bihao Wu , Shaohong Chen , Xinghai Zhang , Xiaoying Jia , Rui Gong , Yucai Peng , Huajun Zhang , Sandra Chiu
{"title":"A bivalent Delta/BA.5 mRNA vaccine elicits broad immune responses against various lineages of SARS-CoV-2 including JN.1","authors":"Kangyin Li , Qi Liu , Yan Wu , Bihao Wu , Shaohong Chen , Xinghai Zhang , Xiaoying Jia , Rui Gong , Yucai Peng , Huajun Zhang , Sandra Chiu","doi":"10.1016/j.virs.2024.08.003","DOIUrl":"10.1016/j.virs.2024.08.003","url":null,"abstract":"","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 5","pages":"Pages 833-835"},"PeriodicalIF":5.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141914169","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A multi-center study on genetic variations in the fusion protein of respiratory syncytial virus from children with Acute Lower Respiratory Tract Infections in China during 2017–2021 2017-2021 年中国急性下呼吸道感染患儿呼吸道合胞病毒融合蛋白基因变异多中心研究。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1016/j.virs.2024.09.002
Yiliang Fu , Fei Li , Yun Zhu , Luci Huang , Qiuping Li , Hanwen Zhang , Lili Zhong , Hailin Zhang , Zheng-xiu Luo , Gen Lu , Jikui Deng , Lingfeng Cao , Ying Wu , Rong Jin , Lei Li , Lili Xu , Xiangpeng Chen , Zhengde Xie
Respiratory syncytial virus (RSV) is a significant cause of acute lower respiratory tract infection (ALRTI) in children under five years of age. Between 2017 and 2021, 396 complete sequences of the RSV F gene were obtained from 500 RSV-positive throat swabs collected from ten hospitals across nine provinces in China. In addition, 151 sequences from China were sourced from GenBank and GISAID, making a total of 549 RSV F gene sequences subjected to analysis. Phylogenetic and genetic diversity analyses revealed that the RSV F genes circulating in China from 2017 to 2021 have remained relatively conserved, although some amino acids (AAs) have undergone changes. AA mutations with frequencies ≥ 10% were identified at six sites and the p27 region: V384I (site I), N276S (site II), R213S (site Ø), and K124N (p27) for RSV A; F45L (site I), M152I/L172Q/S173 ​L/I185V/K191R (site V), and R202Q/I206M/Q209R (site Ø) for RSV B. Comparing mutational frequencies in RSV-F before and after 2020 revealed minor changes for RSV A, while the K191R, I206M, and Q209R frequencies increased by over 10% in RSV B. Notably, the nirsevimab-resistant mutation, S211N in RSV B, increased in frequency from 0% to 1.15%. Both representative strains aligned with the predicted RSV-F structures of their respective prototypes exhibited similar conformations, with low root-mean-square deviation values. These results could provide foundational data from China for the development of RSV mAbs and vaccines.
呼吸道合胞病毒(RSV)是导致五岁以下儿童急性下呼吸道感染(ALRTI)的重要原因。2017年至2021年间,从中国9个省10家医院采集的500份RSV阳性咽拭子中获得了396个RSV F基因的完整序列。此外,还从 GenBank 和 GISAID 中获取了 151 条来自中国的序列,因此共有 549 条 RSV F 基因序列接受了分析。系统发育和遗传多样性分析显示,2017年至2021年在中国流行的RSV F基因保持了相对保守的状态,但部分氨基酸(AA)发生了变化。在6个位点和p27区域发现了频率≥10%的AA突变:在 RSV A 中发现了 V384I(位点 I)、N276S(位点 II)、R213S(位点 Ø)和 K124N(p27);在 RSV B 中发现了 F45L(位点 I)、M152I/L172Q/S173L/I185V/K191R(位点 V)和 R202Q/I206M/Q209R(位点 Ø)。比较 2020 年前后 RSV-F 的突变频率发现,RSV A 的突变频率变化较小,而 RSV B 的 K191R、I206M 和 Q209R 频率增加了 10%以上。与各自原型的 RSV-F 预测结构对齐的两个代表性菌株均表现出相似的构象,均方根偏差值较低。这些结果可为中国开发 RSV mAbs 和疫苗提供基础数据。
{"title":"A multi-center study on genetic variations in the fusion protein of respiratory syncytial virus from children with Acute Lower Respiratory Tract Infections in China during 2017–2021","authors":"Yiliang Fu ,&nbsp;Fei Li ,&nbsp;Yun Zhu ,&nbsp;Luci Huang ,&nbsp;Qiuping Li ,&nbsp;Hanwen Zhang ,&nbsp;Lili Zhong ,&nbsp;Hailin Zhang ,&nbsp;Zheng-xiu Luo ,&nbsp;Gen Lu ,&nbsp;Jikui Deng ,&nbsp;Lingfeng Cao ,&nbsp;Ying Wu ,&nbsp;Rong Jin ,&nbsp;Lei Li ,&nbsp;Lili Xu ,&nbsp;Xiangpeng Chen ,&nbsp;Zhengde Xie","doi":"10.1016/j.virs.2024.09.002","DOIUrl":"10.1016/j.virs.2024.09.002","url":null,"abstract":"<div><div>Respiratory syncytial virus (RSV) is a significant cause of acute lower respiratory tract infection (ALRTI) in children under five years of age. Between 2017 and 2021, 396 complete sequences of the RSV <em>F</em> gene were obtained from 500 RSV-positive throat swabs collected from ten hospitals across nine provinces in China. In addition, 151 sequences from China were sourced from GenBank and GISAID, making a total of 549 RSV <em>F</em> gene sequences subjected to analysis. Phylogenetic and genetic diversity analyses revealed that the RSV <em>F</em> genes circulating in China from 2017 to 2021 have remained relatively conserved, although some amino acids (AAs) have undergone changes. AA mutations with frequencies ≥ 10% were identified at six sites and the p27 region: V384I (site I), N276S (site II), R213S (site Ø), and K124N (p27) for RSV A; F45L (site I), M152I/L172Q/S173 ​L/I185V/K191R (site V), and R202Q/I206M/Q209R (site Ø) for RSV B. Comparing mutational frequencies in RSV-F before and after 2020 revealed minor changes for RSV A, while the K191R, I206M, and Q209R frequencies increased by over 10% in RSV B. Notably, the nirsevimab-resistant mutation, S211N in RSV B, increased in frequency from 0% to 1.15%. Both representative strains aligned with the predicted RSV-F structures of their respective prototypes exhibited similar conformations, with low root-mean-square deviation values. These results could provide foundational data from China for the development of RSV mAbs and vaccines.</div></div>","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 5","pages":"Pages 727-736"},"PeriodicalIF":5.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257550","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Issue Cover 发行封面
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1016/S1995-820X(24)00153-6
{"title":"Issue Cover","authors":"","doi":"10.1016/S1995-820X(24)00153-6","DOIUrl":"10.1016/S1995-820X(24)00153-6","url":null,"abstract":"","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 5","pages":"Page OFC"},"PeriodicalIF":5.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142586871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71 合理设计 DNA 发射的人类肠道病毒 71 型减毒活疫苗。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-10-01 DOI: 10.1016/j.virs.2024.09.008
Rong-Rong Zhang , Meng-Jiao He , Chao Zhou , Yan-Peng Xu , Wei Tang , Tian-Shu Cao , Zheng-Jian Wang , Mei Wu , Tao Ming , Yi-Jiao Huang , Meng-Xu Sun , Hui Zhao , Yong-Qiang Deng , Xiao-Feng Li , Bin Wang , Qing Ye , Cheng-Feng Qin
Human Enterovirus 71 (EV71) has emerged as one of the predominant causative agents of hand, foot and mouth disease (HFMD) with global impact. Despite the inactivated vaccine being licensed, other vaccine candidates based on advanced technology platforms are under development. In this report, we rationally designed and constructed two DNA-launched live attenuated vaccine candidates (pDL-EV71) under the control of specific promoters. In vitro and in vivo transfection with pDL-EV71 driven by the CMV promoter successfully yielded fully infectious EV71. More importantly, the administration of pDL-EV71 did not cause clinical symptoms following intracranial or intramuscular inoculation in neonatal and IFNα/βR−/− mice, demonstrating its safety profile. Moreover, a single-dose or two-dose immunization with pDL-EV71 elicited robust neutralizing antibodies against EV71 as well as an antigen-specific cellular response in mice. A single-dose immunization with 10 ​μg of pDL-EV71 conferred complete protection against lethal EV71 infection in neonates born to immunized maternal mice. Overall, our present results demonstrate that pDL-EV71 is a safe and effective vaccine candidate against EV71 for further development.
人类肠道病毒 71 型(EV71)已成为影响全球的手足口病(HFMD)的主要致病因子之一。尽管灭活疫苗已获得许可,但基于先进技术平台的其他候选疫苗仍在开发中。在本报告中,我们在特定启动子的控制下合理设计并构建了两种 DNA 发射的减毒活疫苗候选株(pDL-EV71)。由 CMV 启动子驱动的 pDL-EV71 在体外和体内转染成功地产生了具有完全感染性的 EV71。更重要的是,在新生小鼠和 IFNα/βR-/- 小鼠颅内或肌肉注射 pDL-EV71 后,不会引起临床症状,这证明了其安全性。此外,pDL-EV71 的单剂量或双剂量免疫可在小鼠体内激发针对 EV71 的强效中和抗体以及抗原特异性细胞反应。单剂量免疫 10 μg pDL-EV71 可完全保护免疫母鼠所生的新生儿免受致死性 EV71 感染。总之,我们目前的研究结果表明,pDL-EV71 是一种安全有效的 EV71 候选疫苗,可供进一步开发。
{"title":"Rational design of a DNA-launched live attenuated vaccine against human enterovirus 71","authors":"Rong-Rong Zhang ,&nbsp;Meng-Jiao He ,&nbsp;Chao Zhou ,&nbsp;Yan-Peng Xu ,&nbsp;Wei Tang ,&nbsp;Tian-Shu Cao ,&nbsp;Zheng-Jian Wang ,&nbsp;Mei Wu ,&nbsp;Tao Ming ,&nbsp;Yi-Jiao Huang ,&nbsp;Meng-Xu Sun ,&nbsp;Hui Zhao ,&nbsp;Yong-Qiang Deng ,&nbsp;Xiao-Feng Li ,&nbsp;Bin Wang ,&nbsp;Qing Ye ,&nbsp;Cheng-Feng Qin","doi":"10.1016/j.virs.2024.09.008","DOIUrl":"10.1016/j.virs.2024.09.008","url":null,"abstract":"<div><div>Human Enterovirus 71 (EV71) has emerged as one of the predominant causative agents of hand, foot and mouth disease (HFMD) with global impact. Despite the inactivated vaccine being licensed, other vaccine candidates based on advanced technology platforms are under development. In this report, we rationally designed and constructed two DNA-launched live attenuated vaccine candidates (pDL-EV71) under the control of specific promoters. <em>In vitro</em> and <em>in vivo</em> transfection with pDL-EV71 driven by the CMV promoter successfully yielded fully infectious EV71. More importantly, the administration of pDL-EV71 did not cause clinical symptoms following intracranial or intramuscular inoculation in neonatal and IFNα/βR<sup>−/−</sup> mice, demonstrating its safety profile. Moreover, a single-dose or two-dose immunization with pDL-EV71 elicited robust neutralizing antibodies against EV71 as well as an antigen-specific cellular response in mice. A single-dose immunization with 10 ​μg of pDL-EV71 conferred complete protection against lethal EV71 infection in neonates born to immunized maternal mice. Overall, our present results demonstrate that pDL-EV71 is a safe and effective vaccine candidate against EV71 for further development.</div></div>","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 5","pages":"Pages 812-820"},"PeriodicalIF":5.5,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142296610","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters. 基于铁蛋白纳米颗粒的尼帕病毒糖蛋白疫苗可在小鼠和仓鼠体内引起有效的保护性免疫反应。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-09-16 DOI: 10.1016/j.virs.2024.09.005
Shaohong Chen,Xinghai Zhang,Yanfeng Yao,Shengdong Wang,Kangyin Li,Baoyue Zhang,Tianxi Ye,Li Chen,Yan Wu,Entao Li,Bichao Xu,Pei Zhang,Xia Chuai,Yong Ran,Rui Gong,Huajun Zhang,Sandra Chiu
Nipah virus (NiV) is a zoonotic paramyxovirus in the genus Henipavirus that is prevalent in Southeast Asia. NiV leads to severe respiratory disease and encephalitis in humans and animals, with a mortality rate of up to 75%. Despite the grave threat to public health and global biosecurity, no medical countermeasures are available for humans. Here, based on self-assembled ferritin nanoparticles (FeNPs), we successfully constructed two candidate FeNP vaccines by loading mammalian cells expressing NiV sG (residues 71-602, FeNP-sG) and Ghead (residues 182-602, FeNP-Ghead) onto E. coli-expressed FeNPs (FeNP-sG and FeNP-Ghead, respectively) through Spycatcher/Spytag technology. Compared with sG and Ghead alone, FeNP-sG and FeNP-Ghead elicited significant NiV specific neutralizing antibody levels and T-cell responses in mice, whereas the immune response in the FeNP-sG immunized group was greater than that in the FeNP-Ghead group. These results further demonstrate that sG possesses greater antigenicity than Ghead and that FeNPs can dramatically enhance immunogenicity. Furthermore, FeNP-sG provided 100% protection against NiV challenge in a hamster model when it was administered twice at a dose of 5 μg/per animal. Our study provides not only a promising candidate vaccine against NiV, but also a theoretical foundation for the design of a NiV immunogen for the development of novel strategies against NiV infection.
尼帕病毒(Nipah virus,NiV)是一种人畜共患病副黏液病毒,属于轩尼巴病毒属,在东南亚流行。尼帕病毒会导致人类和动物患上严重的呼吸道疾病和脑炎,死亡率高达 75%。尽管这种病毒对公共卫生和全球生物安全构成严重威胁,但目前还没有针对人类的医疗对策。在此,我们以自组装铁蛋白纳米颗粒(FeNPs)为基础,通过Spycatcher/Spytag技术将表达NiV sG(残基71-602,FeNP-sG)和Ghead(残基182-602,FeNP-Ghead)的哺乳动物细胞装载到大肠杆菌表达的FeNPs(分别为FeNP-sG和FeNP-Ghead)上,成功构建了两种候选FeNP疫苗。与单独使用 sG 和 Ghead 相比,FeNP-sG 和 FeNP-Ghead 在小鼠体内引起了显著的 NiV 特异性中和抗体水平和 T 细胞反应,而 FeNP-sG 免疫组的免疫反应高于 FeNP-Ghead 组。这些结果进一步证明,sG 比 Ghead 具有更强的抗原性,FeNPs 可以显著增强免疫原性。此外,在仓鼠模型中,FeNP-sG 以每只动物 5 微克的剂量给药两次,可提供 100% 的抗 NiV 保护。我们的研究不仅为NiV候选疫苗的开发提供了希望,也为NiV免疫原的设计提供了理论基础,从而为开发新型抗NiV感染策略奠定了基础。
{"title":"Ferritin nanoparticle-based Nipah virus glycoprotein vaccines elicit potent protective immune responses in mice and hamsters.","authors":"Shaohong Chen,Xinghai Zhang,Yanfeng Yao,Shengdong Wang,Kangyin Li,Baoyue Zhang,Tianxi Ye,Li Chen,Yan Wu,Entao Li,Bichao Xu,Pei Zhang,Xia Chuai,Yong Ran,Rui Gong,Huajun Zhang,Sandra Chiu","doi":"10.1016/j.virs.2024.09.005","DOIUrl":"https://doi.org/10.1016/j.virs.2024.09.005","url":null,"abstract":"Nipah virus (NiV) is a zoonotic paramyxovirus in the genus Henipavirus that is prevalent in Southeast Asia. NiV leads to severe respiratory disease and encephalitis in humans and animals, with a mortality rate of up to 75%. Despite the grave threat to public health and global biosecurity, no medical countermeasures are available for humans. Here, based on self-assembled ferritin nanoparticles (FeNPs), we successfully constructed two candidate FeNP vaccines by loading mammalian cells expressing NiV sG (residues 71-602, FeNP-sG) and Ghead (residues 182-602, FeNP-Ghead) onto E. coli-expressed FeNPs (FeNP-sG and FeNP-Ghead, respectively) through Spycatcher/Spytag technology. Compared with sG and Ghead alone, FeNP-sG and FeNP-Ghead elicited significant NiV specific neutralizing antibody levels and T-cell responses in mice, whereas the immune response in the FeNP-sG immunized group was greater than that in the FeNP-Ghead group. These results further demonstrate that sG possesses greater antigenicity than Ghead and that FeNPs can dramatically enhance immunogenicity. Furthermore, FeNP-sG provided 100% protection against NiV challenge in a hamster model when it was administered twice at a dose of 5 μg/per animal. Our study provides not only a promising candidate vaccine against NiV, but also a theoretical foundation for the design of a NiV immunogen for the development of novel strategies against NiV infection.","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"10 1","pages":""},"PeriodicalIF":5.5,"publicationDate":"2024-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142257547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bis-benzylisoquinoline alkaloids inhibit flavivirus entry and replication by compromising endolysosomal trafficking and autophagy. 双苄基异喹啉生物碱通过影响内溶酶体转运和自噬抑制黄病毒的进入和复制。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-09-07 DOI: 10.1016/j.virs.2024.09.001
Lihong Huang,Lele Liu,Junhai Zhu,Nanjun Chen,Jie Chen,Chuen-Fuk Chan,Fei Gao,Youqin Yin,Jiufeng Sun,Rongxin Zhang,Kehui Zhang,Wenbao Qi,Jianbo Yue
Flaviviruses, such as dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV), represent a substantial public health challenge as there are currently no approved treatments available. Here, we investigated the antiviral effects of bis-benzylisoquinoline alkaloids (BBAs) on flavivirus infections. We evaluated five specific BBAs-berbamine, tetrandrine, iso-tetrandrine, fangchinoline, and cepharanthine-and found that they effectively inhibited infections by ZIKV, DENV, or JEV by blocking virus entry and genome replication stages in the flavivirus life cycle. Furthermore, we synthesized a fluorophore-conjugated BBA and showed that BBAs targeted endolysosomes, causing lysosomal pH alkalization. Mechanistic studies on inhibiting ZIKV infection by BBAs revealed that these compounds blocked TRPML channels, leading to lysosomal dysfunction and reducing the expression of NCAM1, a key receptor for the entry of ZIKV into cells, thereby decreasing cells susceptibility to ZIKV infection. Additionally, BBAs inhibited the fusion of autophagosomes and lysosomes, significantly reducing viral RNA replication. Collectively, our results suggest that BBAs inhibit flavivirus entry and replication by compromising endolysosomal trafficking and autophagy, respectively, underscoring the potential of BBAs as therapeutic agents against flavivirus infections.
登革病毒(DENV)、寨卡病毒(ZIKV)和日本脑炎病毒(JEV)等黄病毒是公共卫生面临的重大挑战,因为目前还没有获得批准的治疗方法。在这里,我们研究了双苄基异喹啉生物碱(BBAs)对黄病毒感染的抗病毒作用。我们评估了五种特定的 BBA--小檗胺、四氢喹啉、异四氢喹啉、芳喹啉和头花苋碱--发现它们通过阻断黄病毒生命周期中病毒进入和基因组复制阶段,有效抑制了 ZIKV、DENV 或 JEV 的感染。此外,我们还合成了一种含荧光团的 BBA,结果表明 BBA 可靶向内溶酶体,使溶酶体 pH 碱化。对 BBAs 抑制 ZIKV 感染的机理研究发现,这些化合物阻断了 TRPML 通道,导致溶酶体功能紊乱,减少了 ZIKV 进入细胞的关键受体 NCAM1 的表达,从而降低了细胞对 ZIKV 感染的易感性。此外,BBAs 还能抑制自噬体和溶酶体的融合,从而显著减少病毒 RNA 的复制。总之,我们的研究结果表明,BBAs 可分别通过损害溶酶体内转运和自噬作用来抑制黄病毒的进入和复制,突出了 BBAs 作为黄病毒感染治疗剂的潜力。
{"title":"Bis-benzylisoquinoline alkaloids inhibit flavivirus entry and replication by compromising endolysosomal trafficking and autophagy.","authors":"Lihong Huang,Lele Liu,Junhai Zhu,Nanjun Chen,Jie Chen,Chuen-Fuk Chan,Fei Gao,Youqin Yin,Jiufeng Sun,Rongxin Zhang,Kehui Zhang,Wenbao Qi,Jianbo Yue","doi":"10.1016/j.virs.2024.09.001","DOIUrl":"https://doi.org/10.1016/j.virs.2024.09.001","url":null,"abstract":"Flaviviruses, such as dengue virus (DENV), Zika virus (ZIKV), and Japanese encephalitis virus (JEV), represent a substantial public health challenge as there are currently no approved treatments available. Here, we investigated the antiviral effects of bis-benzylisoquinoline alkaloids (BBAs) on flavivirus infections. We evaluated five specific BBAs-berbamine, tetrandrine, iso-tetrandrine, fangchinoline, and cepharanthine-and found that they effectively inhibited infections by ZIKV, DENV, or JEV by blocking virus entry and genome replication stages in the flavivirus life cycle. Furthermore, we synthesized a fluorophore-conjugated BBA and showed that BBAs targeted endolysosomes, causing lysosomal pH alkalization. Mechanistic studies on inhibiting ZIKV infection by BBAs revealed that these compounds blocked TRPML channels, leading to lysosomal dysfunction and reducing the expression of NCAM1, a key receptor for the entry of ZIKV into cells, thereby decreasing cells susceptibility to ZIKV infection. Additionally, BBAs inhibited the fusion of autophagosomes and lysosomes, significantly reducing viral RNA replication. Collectively, our results suggest that BBAs inhibit flavivirus entry and replication by compromising endolysosomal trafficking and autophagy, respectively, underscoring the potential of BBAs as therapeutic agents against flavivirus infections.","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"144 1","pages":""},"PeriodicalIF":5.5,"publicationDate":"2024-09-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142180133","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antigenic analysis of the influenza B virus hemagglutinin protein. 乙型流感病毒血凝素蛋白的抗原分析。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-09-02 DOI: 10.1016/j.virs.2024.08.012
Mengyi Zhang, Chaoying Yang, Xi Wu, Yifei Wang, Lijie Wang, Qianqian Cui, Jincheng Tong, Yimeng An, Meina Cai, Shishi Cheng, Qi Jiang, Yulin Wang, Chenyan Zhao, Youchun Wang, Weijin Huang

Influenza B viruses (IBVs) primarily infect humans and are a common cause of respiratory infections in humans. Here, to systematically analyze the antigenicity of the IBVs Hemagglutinin (HA) protein, 31 ​B/Victoria and 19 ​B/Yamagata representative circulating strains were selected from Global Initiative of Sharing All Influenza Data (GISAID), and pseudotyped viruses were constructed with the vesicular stomatitis virus system. Guinea pigs were immunized with three doses of vaccines (one dose of DNA vaccines following two doses of pseudotyped virus vaccines) of the seven IBV vaccine strains, and neutralizing antibodies against the pseudotyped viruses were tested. By comparing differences between various vaccine strains, we constructed several pseudotyped viruses that contained various mutations based on vaccine strain BV-21. The vaccine strains showed good neutralization levels against the epidemic virus strains of the same year, with neutralization titers ranging from 370 to 840, while the level of neutralization against viruses prevalent in previous years decreased 1-10-fold. Each of the high-frequency epidemic strains of B/Victoria and B/Yamagata not only induced high neutralizing titers, but also had broadly neutralizing effects against virus strains of different years, with neutralizing titers ranging from 1000 to 7200. R141G, D197 ​N, and R203K were identified as affecting the antigenicity of IBV. These mutation sites provide valuable references for the selection and design of a universal IBV vaccine strain in the future.

乙型流感病毒(IBV)主要感染人类,是人类呼吸道感染的常见病因。为了系统分析乙型流感病毒血凝素(HA)蛋白的抗原性,研究人员从全球流感数据共享倡议(GISAID)中筛选出31株乙型/维多利亚和19株乙型/山形具有代表性的流行毒株,并利用水泡性口炎病毒系统构建了伪型病毒。豚鼠接种了三剂七种 IBV 疫苗株的疫苗(一剂 DNA 疫苗和两剂伪型病毒疫苗),并检测了针对伪型病毒的中和抗体。通过比较不同疫苗株之间的差异,我们在疫苗株 BV-21 的基础上构建了几种含有不同突变的伪型病毒。疫苗毒株对当年流行的病毒毒株显示出良好的中和水平,中和滴度从 370 到 840 不等,而对往年流行病毒的中和水平则下降了 1-10 倍。B/Victoria和B/Yamagata的每个高频流行株不仅能诱导高中和滴度,而且对不同年份的病毒株具有广泛的中和作用,中和滴度从1000到7200不等。研究发现,R141G、D197N 和 R203K 会影响 IBV 的抗原性。本研究采用假病毒系统监测高发流行株与世界卫生组织推荐的疫苗株的交叉中和效力。此外,我们还发现了三个会严重影响 B/Victoria 疫苗株抗原性的突变位点。这些突变位点为将来选择和设计通用的 IBV 疫苗株提供了有价值的参考。
{"title":"Antigenic analysis of the influenza B virus hemagglutinin protein.","authors":"Mengyi Zhang, Chaoying Yang, Xi Wu, Yifei Wang, Lijie Wang, Qianqian Cui, Jincheng Tong, Yimeng An, Meina Cai, Shishi Cheng, Qi Jiang, Yulin Wang, Chenyan Zhao, Youchun Wang, Weijin Huang","doi":"10.1016/j.virs.2024.08.012","DOIUrl":"10.1016/j.virs.2024.08.012","url":null,"abstract":"<p><p>Influenza B viruses (IBVs) primarily infect humans and are a common cause of respiratory infections in humans. Here, to systematically analyze the antigenicity of the IBVs Hemagglutinin (HA) protein, 31 ​B/Victoria and 19 ​B/Yamagata representative circulating strains were selected from Global Initiative of Sharing All Influenza Data (GISAID), and pseudotyped viruses were constructed with the vesicular stomatitis virus system. Guinea pigs were immunized with three doses of vaccines (one dose of DNA vaccines following two doses of pseudotyped virus vaccines) of the seven IBV vaccine strains, and neutralizing antibodies against the pseudotyped viruses were tested. By comparing differences between various vaccine strains, we constructed several pseudotyped viruses that contained various mutations based on vaccine strain BV-21. The vaccine strains showed good neutralization levels against the epidemic virus strains of the same year, with neutralization titers ranging from 370 to 840, while the level of neutralization against viruses prevalent in previous years decreased 1-10-fold. Each of the high-frequency epidemic strains of B/Victoria and B/Yamagata not only induced high neutralizing titers, but also had broadly neutralizing effects against virus strains of different years, with neutralizing titers ranging from 1000 to 7200. R141G, D197 ​N, and R203K were identified as affecting the antigenicity of IBV. These mutation sites provide valuable references for the selection and design of a universal IBV vaccine strain in the future.</p>","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":" ","pages":""},"PeriodicalIF":5.5,"publicationDate":"2024-09-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142133919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transmission restriction and genomic evolution co-shape the genetic diversity patterns of influenza A virus 传播限制和基因组进化共同塑造了甲型流感病毒的遗传多样性模式。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.virs.2024.02.005

Influenza A virus (IAV) shows an extensive host range and rapid genomic variations, leading to continuous emergence of novel viruses with significant antigenic variations and the potential for cross-species transmission. This causes global pandemics and seasonal flu outbreaks, posing sustained threats worldwide. Thus, studying all IAVs' evolutionary patterns and underlying mechanisms is crucial for effective prevention and control. We developed FluTyping to identify IAV genotypes, to explore overall genetic diversity patterns and their restriction factors. FluTyping groups isolates based on genetic distance and phylogenetic relationships using whole genomes, enabling identification of each isolate's genotype. Three distinct genetic diversity patterns were observed: one genotype domination pattern comprising only H1N1 and H3N2 seasonal influenza subtypes, multi-genotypes co-circulation pattern including majority avian influenza subtypes and swine influenza H1N2, and hybrid-circulation pattern involving H7N9 and three H5 subtypes of influenza viruses. Furthermore, the IAVs in multi-genotypes co-circulation pattern showed region-specific dominant genotypes, implying the restriction of virus transmission is a key factor contributing to distinct genetic diversity patterns, and the genomic evolution underlying different patterns was more influenced by host-specific factors. In summary, a comprehensive picture of the evolutionary patterns of overall IAVs is provided by the FluTyping's identified genotypes, offering important theoretical foundations for future prevention and control of these viruses.

甲型流感病毒(IAV)的宿主范围广泛,基因组变异迅速,导致不断出现具有显著抗原变异和跨物种传播潜力的新型病毒。这导致了全球性流感大流行和季节性流感爆发,对全球构成持续威胁。因此,研究所有 IAV 的进化模式和内在机制对于有效预防和控制至关重要。我们开发了 FluTyping 来识别 IAV 基因型,探索整体遗传多样性模式及其限制因素。FluTyping 利用全基因组,根据遗传距离和系统发育关系对分离株进行分组,从而确定每个分离株的基因型。观察到三种不同的遗传多样性模式:一种基因型主导模式,仅包括 H1N1 和 H3N2 季节性流感亚型;多基因型共循环模式,包括大多数禽流感亚型和猪流感 H1N2;以及混合循环模式,包括 H7N9 和三种 H5 亚型流感病毒。此外,多基因型共循环模式中的 IAV 表现出区域特异性的优势基因型,这意味着病毒传播的限制是导致不同基因多样性模式的关键因素,而不同模式背后的基因组进化则更多地受到宿主特异性因素的影响。总之,FluTyping 发现的基因型全面反映了整个 IAV 的进化模式,为今后防控这些病毒提供了重要的理论依据。
{"title":"Transmission restriction and genomic evolution co-shape the genetic diversity patterns of influenza A virus","authors":"","doi":"10.1016/j.virs.2024.02.005","DOIUrl":"10.1016/j.virs.2024.02.005","url":null,"abstract":"<div><p>Influenza A virus (IAV) shows an extensive host range and rapid genomic variations, leading to continuous emergence of novel viruses with significant antigenic variations and the potential for cross-species transmission. This causes global pandemics and seasonal flu outbreaks, posing sustained threats worldwide. Thus, studying all IAVs' evolutionary patterns and underlying mechanisms is crucial for effective prevention and control. We developed FluTyping to identify IAV genotypes, to explore overall genetic diversity patterns and their restriction factors. FluTyping groups isolates based on genetic distance and phylogenetic relationships using whole genomes, enabling identification of each isolate's genotype. Three distinct genetic diversity patterns were observed: one genotype domination pattern comprising only H1N1 and H3N2 seasonal influenza subtypes, multi-genotypes co-circulation pattern including majority avian influenza subtypes and swine influenza H1N2, and hybrid-circulation pattern involving H7N9 and three H5 subtypes of influenza viruses. Furthermore, the IAVs in multi-genotypes co-circulation pattern showed region-specific dominant genotypes, implying the restriction of virus transmission is a key factor contributing to distinct genetic diversity patterns, and the genomic evolution underlying different patterns was more influenced by host-specific factors. In summary, a comprehensive picture of the evolutionary patterns of overall IAVs is provided by the FluTyping's identified genotypes, offering important theoretical foundations for future prevention and control of these viruses.</p></div>","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 4","pages":"Pages 525-536"},"PeriodicalIF":5.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1995820X24000257/pdfft?md5=c9047b76f99283ea406765a10aa07add&pid=1-s2.0-S1995820X24000257-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139997623","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Individual virome analysis reveals the general co-infection of mammal-associated viruses with SARS-related coronaviruses in bats 单个病毒组分析表明,哺乳动物相关病毒与蝙蝠体内与严重急性呼吸系统综合症有关的冠状病毒普遍混合感染。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.virs.2024.06.008

Bats are the natural reservoir hosts for SARS-related coronavirus (SARSr-CoV) and other highly pathogenic microorganisms. Therefore, it is conceivable that an individual bat may harbor multiple microbes. However, there is limited knowledge on the overall co-circulation of microorganisms in bats. Here, we conducted a 16-year monitoring of bat viruses in south and central China and identified 238 SARSr-CoV positive samples across nine bat species from ten provinces or administrative districts. Among these, 76 individual samples were selected for further metagenomics analysis. We found a complex microenvironment characterized by the general co-circulation of microbes from two different sources: mammal-associated viruses or environment-associated microbes. The later includes commensal bacteria, enterobacteria-related phages, and insect or fungal viruses of food origin. Results showed that 25% (19/76) of the samples contained at least one another mammal-associated virus, notably alphacoronaviruses (13/76) such as AlphaCoV/YN2012, HKU2-related CoV and AlphaCoV/Rf-HuB2013, along with viruses from other families. Notably, we observed three viruses co-circulating within a single bat, comprising two coronavirus species and one picornavirus. Our analysis also revealed the potential presence of pathogenic bacteria or fungi in bats. Furthermore, we obtained 25 viral genomes from the 76 bat SARSr-CoV positive samples, some of which formed new evolutionary lineages. Collectively, our study reveals the complex microenvironment of bat microbiome, facilitating deeper investigations into their pathogenic potential and the likelihood of cross-species transmission.

蝙蝠是严重急性呼吸系统综合症相关冠状病毒(SARSr-CoV)和其他高致病性微生物的天然宿主。因此,可以想象一只蝙蝠可能携带多种微生物。然而,人们对蝙蝠体内微生物的总体共同循环情况了解有限。在此,我们对中国华南和华中地区的蝙蝠病毒进行了长达 16 年的监测,发现了 238 份 SARSr-CoV 阳性样本,涉及 10 个省或行政区的 9 种蝙蝠。在这些样本中,我们选择了 76 个样本进行进一步的元基因组学分析。我们发现了一个复杂的微环境,其特点是微生物的普遍共循环,这些微生物有两种不同的来源:与哺乳动物相关的病毒或与环境相关的微生物。后者包括共生细菌、与肠杆菌相关的噬菌体以及源于食物的昆虫或真菌病毒。结果显示,25%(19/76)的样本至少含有一种哺乳动物相关病毒,尤其是阿尔法冠状病毒(13/76),如 AlphaCoV/YN2012、HKU2 相关 CoV 和 AlphaCoV/Rf-HuB2013,以及其他科的病毒。值得注意的是,我们观察到有三种病毒在一只蝙蝠体内同时存在,其中包括两种冠状病毒和一种皮卡病毒。我们的分析还揭示了蝙蝠体内可能存在的致病细菌或真菌。此外,我们还从 76 个 SARSr-CoV 阳性蝙蝠样本中获得了 25 个病毒基因组,其中一些形成了新的进化系。总之,我们的研究揭示了蝙蝠微生物组的复杂微环境,有助于深入研究它们的致病潜力和跨物种传播的可能性。
{"title":"Individual virome analysis reveals the general co-infection of mammal-associated viruses with SARS-related coronaviruses in bats","authors":"","doi":"10.1016/j.virs.2024.06.008","DOIUrl":"10.1016/j.virs.2024.06.008","url":null,"abstract":"<div><p>Bats are the natural reservoir hosts for SARS-related coronavirus (SARSr-CoV) and other highly pathogenic microorganisms. Therefore, it is conceivable that an individual bat may harbor multiple microbes. However, there is limited knowledge on the overall co-circulation of microorganisms in bats. Here, we conducted a 16-year monitoring of bat viruses in south and central China and identified 238 SARSr-CoV positive samples across nine bat species from ten provinces or administrative districts. Among these, 76 individual samples were selected for further metagenomics analysis. We found a complex microenvironment characterized by the general co-circulation of microbes from two different sources: mammal-associated viruses or environment-associated microbes. The later includes commensal bacteria, enterobacteria-related phages, and insect or fungal viruses of food origin. Results showed that 25% (19/76) of the samples contained at least one another mammal-associated virus, notably alphacoronaviruses (13/76) such as AlphaCoV/YN2012, HKU2-related CoV and AlphaCoV/Rf-HuB2013, along with viruses from other families. Notably, we observed three viruses co-circulating within a single bat, comprising two coronavirus species and one picornavirus. Our analysis also revealed the potential presence of pathogenic bacteria or fungi in bats. Furthermore, we obtained 25 viral genomes from the 76 bat SARSr-CoV positive samples, some of which formed new evolutionary lineages. Collectively, our study reveals the complex microenvironment of bat microbiome, facilitating deeper investigations into their pathogenic potential and the likelihood of cross-species transmission.</p></div>","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 4","pages":"Pages 565-573"},"PeriodicalIF":5.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1995820X2400107X/pdfft?md5=95d5d8994d71b59e3d52f410e01cb7a3&pid=1-s2.0-S1995820X2400107X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141471095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Continued evolution of H10N3 influenza virus with adaptive mutations poses an increased threat to mammals 具有适应性突变的 H10N3 流感病毒不断进化,对哺乳动物的威胁日益严重。
IF 5.5 3区 医学 Q1 Medicine Pub Date : 2024-08-01 DOI: 10.1016/j.virs.2024.06.005

The H10 subtype avian influenza virus (AIV) poses an ongoing threat to both birds and humans. Notably, fatal human cases of H10N3 and H10N8 infections have drawn public attention. In 2022, we isolated two H10N3 viruses (A/chicken/Shandong/0101/2022 and A/chicken/Shandong/0603/2022) from diseased chickens in China. Genome analysis revealed that these viruses were genetically associated with human-origin H10N3 virus, with internal genes originating from local H9N2 viruses. Compared to the H10N8 virus (A/chicken/Jiangxi/102/2013), the H10N3 viruses exhibited enhanced thermostability, increased viral release from erythrocytes, and accumulation of hemagglutinin (HA) protein. Additionally, we evaluated the pathogenicity of both H10N3 and H10N8 viruses in mice. We found that viral titers could be detected in the lungs and nasal turbinates of mice infected with the two H10N3 viruses, whereas H10N8 virus titers were detectable in the lungs and brains of mice. Notably, the proportion of double HA Q222R and G228S mutations in H10N3 viruses has increased since 2019. However, the functional roles of the Q222R and G228S double mutations in the HA gene of H10N3 viruses remain unknown and warrant further investigation. Our study highlights the potential public health risk posed by the H10N3 virus. A spillover event of AIV to humans could be a foretaste of a looming pandemic. Therefore, it is imperative to continuously monitor the evolution of the H10N3 influenza virus to ensure targeted prevention and control measures against influenza outbreaks.

H10 亚型禽流感病毒(AIV)对鸟类和人类都构成持续威胁。值得注意的是,人类感染 H10N3 和 H10N8 的致命病例引起了公众的关注。2022 年,我们从中国的病鸡中分离出两株 H10N3 株系(A/chicken/Shandong/0101/2022 和 A/chicken/Shandong/0603/2022)。基因组分析表明,这些毒株在基因上与源于人类的 H10N3 病毒有关,其内部基因源于当地的 H9N2 病毒。与 H10N8 株系(A/chicken/Jiangxi/102/2013)相比,H10N3 株系表现出更强的热稳定性、更高的红细胞病毒释放率以及血凝素(HA)蛋白的积累。此外,我们还评估了 H10N3 和 H10N8 病毒在小鼠体内的致病性。我们发现,在感染两种 H10N3 病毒的小鼠肺部和鼻甲中可检测到病毒滴度,而在小鼠肺部和大脑中可检测到 H10N8 病毒滴度。值得注意的是,自2019年以来,H10N3病毒中双HA Q222R和G228S突变的比例有所增加。然而,H10N3 病毒 HA 基因中 Q222R 和 G228S 双突变的功能作用仍然未知,值得进一步研究。我们的研究凸显了 H10N3 病毒带来的潜在公共卫生风险。甲型禽流感病毒向人类扩散可能是大流行迫在眉睫的前兆。因此,当务之急是持续监测 H10N3 流感病毒的演变,以确保针对流感爆发采取有针对性的防控措施。
{"title":"Continued evolution of H10N3 influenza virus with adaptive mutations poses an increased threat to mammals","authors":"","doi":"10.1016/j.virs.2024.06.005","DOIUrl":"10.1016/j.virs.2024.06.005","url":null,"abstract":"<div><p>The H10 subtype avian influenza virus (AIV) poses an ongoing threat to both birds and humans. Notably, fatal human cases of H10N3 and H10N8 infections have drawn public attention. In 2022, we isolated two H10N3 viruses (A/chicken/Shandong/0101/2022 and A/chicken/Shandong/0603/2022) from diseased chickens in China. Genome analysis revealed that these viruses were genetically associated with human-origin H10N3 virus, with internal genes originating from local H9N2 viruses. Compared to the H10N8 virus (A/chicken/Jiangxi/102/2013), the H10N3 viruses exhibited enhanced thermostability, increased viral release from erythrocytes, and accumulation of hemagglutinin (HA) protein. Additionally, we evaluated the pathogenicity of both H10N3 and H10N8 viruses in mice. We found that viral titers could be detected in the lungs and nasal turbinates of mice infected with the two H10N3 viruses, whereas H10N8 virus titers were detectable in the lungs and brains of mice. Notably, the proportion of double HA Q222R and G228S mutations in H10N3 viruses has increased since 2019. However, the functional roles of the Q222R and G228S double mutations in the <em>HA</em> gene of H10N3 viruses remain unknown and warrant further investigation. Our study highlights the potential public health risk posed by the H10N3 virus. A spillover event of AIV to humans could be a foretaste of a looming pandemic. Therefore, it is imperative to continuously monitor the evolution of the H10N3 influenza virus to ensure targeted prevention and control measures against influenza outbreaks.</p></div>","PeriodicalId":23654,"journal":{"name":"Virologica Sinica","volume":"39 4","pages":"Pages 546-555"},"PeriodicalIF":5.5,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S1995820X24000841/pdfft?md5=d1f4fe4ffce86ca2a5944e97cfc3a2eb&pid=1-s2.0-S1995820X24000841-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141318426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Virologica Sinica
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1